These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20219298)

  • 1. Age-related macular degeneration: current and novel therapies.
    Prasad PS; Schwartz SD; Hubschman JP
    Maturitas; 2010 May; 66(1):46-50. PubMed ID: 20219298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment of age-related macular degeneration.
    Zarbin M; Szirth B
    Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for age-related macular degeneration.
    Mittra RA
    Minn Med; 2003 Apr; 86(4):40-6. PubMed ID: 12797657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related macular degeneration; therapeutic options].
    La Heij EC; Liem AT; Hendrikse F
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Related Macular Degeneration.
    Mehta S
    Prim Care; 2015 Sep; 42(3):377-91. PubMed ID: 26319344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related macular degeneration: diagnosis and management.
    Cook HL; Patel PJ; Tufail A
    Br Med Bull; 2008; 85():127-49. PubMed ID: 18334518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular degeneration in older adults.
    Moore LW
    Geriatr Nurs; 2001; 22(2):96-9. PubMed ID: 11326218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)].
    Karska-Basta I; Kubicka-Trzaska A; Oleksy P; Romanowska-Dixon B
    Przegl Lek; 2009; 66(11):972-5. PubMed ID: 20297641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of vitreous hemorrhage secondary to exudative age-related macular degeneration.
    Hasegawa T; Otani A; Sasahara M; Gotoh N; Ooto S; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2010 Feb; 149(2):322-329.e1. PubMed ID: 20103057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential effect of population development, smoking and antioxidant supplementation on the future epidemiology of age-related macular degeneration in Switzerland.
    Bauer P; Barthelmes D; Kurz M; Fleischhauer JC; Sutter FK
    Klin Monbl Augenheilkd; 2008 May; 225(5):376-9. PubMed ID: 18454376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration].
    Ambresin A; Mantel I
    Rev Med Suisse; 2007 Jan; 3(94):137-41. PubMed ID: 17354539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotenoids and co-antioxidants in age-related maculopathy: design and methods.
    Neelam K; Hogg RE; Stevenson MR; Johnston E; Anderson R; Beatty S; Chakravarthy U
    Ophthalmic Epidemiol; 2008; 15(6):389-401. PubMed ID: 19065432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for neovascular age-related macular degeneration: state of the art.
    Donati G
    Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration: a leading cause of blindness.
    O'Shea JG
    Med J Aust; 1996 Nov; 165(10):561-4. PubMed ID: 8941243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.